With Iveric Bio buyout, Astellas CEO Okamura acted on the company's mantra to be 'aggressive'

With Iveric Bio buyout, Astellas CEO Okamura acted on the company's mantra to be 'aggressive'

Source: 
Fierce Pharma
snippet: 

Earlier this year, when Astellas announced that Naoki Okamura was taking over as CEO, the Japanese company said that 2023 was the right time for it to “go on the aggressive to further stimulate growth.”